特发性肺纤维化与常见遗传变异相关且罕见变异有限
该研究基于Trans-Omics for Precision Medicine项目对2,180例特发性肺纤维化(IPF)患者进行全基因组测序,聚焦罕见变异(次要等位基因频率≤0.01)在基因或区域内的聚合效应。结果显示TERT和RTEL1基因的罕见变异与IPF显著相关,未发现其他既往报道罕见变异的显著关联,SNP遗传度估计为32%(SE=3%)。结论认为TERT、RTEL1罕见变异及已知常见变异对IPF风险贡献最大。
要点
- TERT和RTEL1基因的罕见变异与IPF显著相关。
- 未发现其他既往报道罕见变异与IPF的显著关联。
- IPF的SNP遗传度估计为32%(SE=3%)。
核心结论
- TERT和RTEL1基因内的罕见变异及已知常见变异对IPF整体风险贡献最大。
- 针对TERT、RTEL1、常见变异及环境风险因素的风险分层或治疗开发可能对IPF影响最大。
研究设计与样本
- 作为Trans-Omics for Precision Medicine项目的一部分,对2,180例IPF病例进行全基因组测序。
- 关联检验聚焦于基因或区域内罕见变异(次要等位基因频率≤0.01)的聚合效应。
- 识别基因内具影响力的单个罕见变异,并基于罕见和常见变异估计IPF遗传度。
主要发现
- TERT和RTEL1的罕见变异与IPF显著相关。
- TERT和RTEL1各有一个单个罕见变异持续影响聚合检验统计量。
- 未发现与其他既往报道罕见变异显著关联的证据。
- IPF的SNP遗传度估计为32%(SE=3%)。
关键数值与推荐
- 罕见变异定义为次要等位基因频率≤0.01。
- IPF的SNP遗传度估计为32%(SE=3%)。
临床怎么用
- 在IPF风险分层中可关注TERT和RTEL1基因的罕见变异及已知常见变异。
- IPF治疗开发可优先考虑针对TERT、RTEL1、常见变异及环境风险因素的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Idiopathic pulmonary fibrosis (IPF) is a rare, irreversible, and progressive disease of the lungs. Common genetic variants, in addition to nongenetic factors, have been consistently associated with IPF. Rare variants identified by candidate gene, family-based, and exome studies have also been reported to associate with IPF. However, the extent to which rare variants, genome-wide, may contribute to the risk of IPF remains unknown. Objectives: We used whole-genome sequencing to investigate the role of rare variants, genome-wide, on IPF risk. Methods: As part of the Trans-Omics for Precision Medicine Program, we sequenced 2,180 cases of IPF. Association testing focused on the aggregated effect of rare variants (minor allele frequency ⩽0.01) within genes or regions. We also identified individual rare variants that are influential within genes and estimated the heritability of IPF on the basis of rare and common variants. Measurements and Main Results: Rare variants in both TERT and RTEL1 were significantly associated with IPF. A single rare variant in each of the TERT and RTEL1 genes was found to consistently influence the aggregated test statistics. There was no significant evidence of association with other previously reported rare variants. The SNP heritability of IPF was estimated to be 32% (SE = 3%). Conclusions: Rare variants within the TERT and RTEL1 genes and well-established common variants have the largest contribution to IPF risk overall. Efforts in risk profiling or the development of therapies for IPF that focus on TERT, RTEL1, common variants, and environmental risk factors are likely to have the largest impact on this complex disease.
引用
- Peljto AL, Blumhagen RZ, Walts AD, et al. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants. Am J Respir Crit Care Med. 2023. PMID: 36602845. doi:10.1164/rccm.202207-1331OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。